S. Leucht

3.1k total citations · 1 hit paper
19 papers, 2.2k citations indexed

About

S. Leucht is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, S. Leucht has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in S. Leucht's work include Schizophrenia research and treatment (11 papers), Treatment of Major Depression (5 papers) and Mental Health and Psychiatry (4 papers). S. Leucht is often cited by papers focused on Schizophrenia research and treatment (11 papers), Treatment of Major Depression (5 papers) and Mental Health and Psychiatry (4 papers). S. Leucht collaborates with scholars based in Germany, United States and United Kingdom. S. Leucht's co-authors include Johannes Hamann, Rolf R. Engel, Jamie Kane, John M. Kane, Werner Kissling, Caroline Corves, C.U. Correll, John M. Davis, Josef Bäuml and Arja Tuunainen and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Schizophrenia Bulletin and Psychopharmacology.

In The Last Decade

S. Leucht

18 papers receiving 2.1k citations

Hit Papers

What does the PANSS mean? 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Leucht Germany 11 1.7k 593 555 308 193 19 2.2k
Donna A. Wirshing United States 28 2.4k 1.3× 483 0.8× 653 1.2× 379 1.2× 133 0.7× 50 3.4k
Mark Taylor United Kingdom 24 2.0k 1.1× 481 0.8× 956 1.7× 235 0.8× 145 0.8× 73 2.9k
C. J. Slooff Netherlands 25 1.7k 1.0× 562 0.9× 706 1.3× 145 0.5× 254 1.3× 69 2.2k
Lakshmi N.P. Voruganti Canada 26 1.9k 1.1× 450 0.8× 1.0k 1.8× 282 0.9× 280 1.5× 34 2.5k
Diego Novick United Kingdom 29 2.7k 1.6× 654 1.1× 924 1.7× 544 1.8× 326 1.7× 128 3.6k
Michael J. Sernyak United States 26 1.3k 0.8× 229 0.4× 305 0.5× 219 0.7× 91 0.5× 58 1.9k
Irene Bighelli Germany 24 1.1k 0.6× 242 0.4× 540 1.0× 232 0.8× 253 1.3× 64 1.8k
Cenk Tek United States 30 1.7k 1.0× 470 0.8× 788 1.4× 192 0.6× 423 2.2× 72 3.0k
J. Peuskens Belgium 11 1.2k 0.7× 272 0.5× 436 0.8× 274 0.9× 159 0.8× 19 1.9k
William Montgomery United States 25 1.3k 0.7× 158 0.3× 469 0.8× 331 1.1× 178 0.9× 88 2.3k

Countries citing papers authored by S. Leucht

Since Specialization
Citations

This map shows the geographic impact of S. Leucht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Leucht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Leucht more than expected).

Fields of papers citing papers by S. Leucht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Leucht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Leucht. The network helps show where S. Leucht may publish in the future.

Co-authorship network of co-authors of S. Leucht

This figure shows the co-authorship network connecting the top 25 collaborators of S. Leucht. A scholar is included among the top collaborators of S. Leucht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Leucht. S. Leucht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bühner, Markus, et al.. (2025). COSMIN systematic review and meta-analysis of the measurement properties of the PANSS-6. European Neuropsychopharmacology. 94. 41–50. 3 indexed citations
2.
Brandt, Lasse, Orestis Efthimiou, Spyridon Siafis, et al.. (2025). Antipsychotic Acute-Phase Treatment in Individuals With and Without Recent Treatment. JAMA Psychiatry. 82(7). 692–692.
3.
Siafis, Spyridon, et al.. (2024). Evidence for music therapy and music medicine in psychiatry: transdiagnostic meta-review of meta-analyses. BJPsych Open. 11(1). e4–e4. 2 indexed citations
4.
Leucht, S., Jim van Os, Markus Jäger, & John M. Davis. (2024). Prioritization of Psychopathological Symptoms and Clinical Characterization in Psychiatric Diagnoses. JAMA Psychiatry. 81(11). 1149–1149. 14 indexed citations
5.
Leucht, S. & Jun Zhao. (2013). P.3.d.021 Early improvement as a predictor of treatment response and remission in patients with acute schizophrenia: effects of asenapine. European Neuropsychopharmacology. 23. S470–S470. 1 indexed citations
6.
Kishimoto, Taishiro, Claudia Leucht, S. Leucht, et al.. (2012). Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials. Schizophrenia Bulletin. 40(1). 192–213. 296 indexed citations
7.
Schechter, Tal, S. Leucht, Éric Bouffet, et al.. (2012). Pulmonary Arteryopathy and Pulmonary Hypertension Following Tandem Autologous Transplants in Pediatric Patients with CNS Tumors. Biology of Blood and Marrow Transplantation. 18(2). S301–S301. 1 indexed citations
8.
Popp, Johannes, S. Leucht, Stephan Heres, & Werner Steimer. (2010). Serotonin transporter polymorphisms and side effects in antidepressant therapy - a pilot study (vol 7, pg 159, 2006). mediaTUM (Technical University of Munich). 1 indexed citations
9.
Stone, James, John M. Davis, S. Leucht, & Lyn S. Pilowsky. (2008). Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature. Schizophrenia Bulletin. 35(4). 789–797. 48 indexed citations
10.
Correll, C.U., et al.. (2008). Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials. Schizophrenia Bulletin. 35(2). 443–457. 272 indexed citations
11.
Leucht, S., Stephan Heres, Johannes Hamann, & John M. Kane. (2007). Methodological Issues in Current Antipsychotic Drug Trials. Schizophrenia Bulletin. 34(2). 275–285. 71 indexed citations
12.
Kane, John M. & S. Leucht. (2007). Unanswered Questions in Schizophrenia Clinical Trials. Schizophrenia Bulletin. 34(2). 302–309. 22 indexed citations
13.
Thienel, Renate, et al.. (2007). Therapie kognitiver Defizite durch AChE-Hemmer bei Patienten mit Schizophrenie. Der Nervenarzt. 79(1). 47–59. 8 indexed citations
14.
Leucht, S., Rolf R. Engel, Josef Bäuml, & John M. Davis. (2006). Is the Superior Efficacy of New Generation Antipsychotics an Artifact of LOCF?. Schizophrenia Bulletin. 33(1). 183–191. 146 indexed citations
15.
Leucht, S., et al.. (2005). What does the PANSS mean?. Schizophrenia Research. 79(2-3). 231–238. 926 indexed citations breakdown →
16.
Hamann, Johannes, S. Leucht, & Werner Kissling. (2003). Shared decision making in psychiatry. Acta Psychiatrica Scandinavica. 107(6). 403–409. 217 indexed citations
17.
Leucht, S., John J. McGrath, Patricia M. White, & Werner Kissling. (2002). Carbamazepine for schizophrenia and schizoaffective psychoses. Cochrane Database of Systematic Reviews. CD001258–CD001258. 22 indexed citations
18.
Wahlbeck, Kristian, Arja Tuunainen, Antti Ahokas, & S. Leucht. (2001). Dropout rates in randomised antipsychotic drug trials. Psychopharmacology. 155(3). 230–233. 141 indexed citations
19.
Leucht, S., et al.. (1999). SERUM LEVELS AND SIDE-EFFECTS OF TRICYCLIC ANTIDEPRESSANTS WITH ADJUNCTIVE PAROXETINE. A PROSPECTIVE STUDY.. Therapeutic Drug Monitoring. 21(4). 458–458. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026